| abstract |
Provided herein are arylcyclopropylamino-isoquinoline amide compounds. In particular, the present disclosure provides compounds that affect the function of kinases in cells and are useful as or in conjunction with therapeutic agents. The compounds of the present disclosure are useful in treating a variety of diseases and conditions, including eye diseases such as glaucoma, cardiovascular diseases, diseases characterized by abnormal growth such as cancer, and inflammatory diseases. The present disclosure further provides compositions containing an isoquinoline amide compound. [Selection diagram] Figure 1 |